Further studies to understand the mechanisms that impair gap junction formation in drug resistant breast cancer cells are required in order to determine if it is possible to force the reestablishment of gap junctions in drug resistant cells by methods beyond Cx43 overexpression. The gene discussed is GJA1; the disease is breast carcinoma.